Co-Authors
This is a "connection" page, showing publications co-authored by MARK S CHAMBERS and ADAM S GARDEN.
Connection Strength
2.551
-
Head and neck radiation and mucositis. Curr Opin Support Palliat Care. 2007 Apr; 1(1):30-4.
Score: 0.294
-
Intensity-modulated radiation therapy and xerostomia. J Calif Dent Assoc. 2006 Sep; 34(9):743-8.
Score: 0.283
-
How to reduce radiation-related toxicity in patients with cancer of the head and neck. Curr Oncol Rep. 2006 Mar; 8(2):140-5.
Score: 0.273
-
A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Oral Oncol. 2020 07; 106:104665.
Score: 0.182
-
Fabrication of an unconventional bolus-type stent for a?combined intraoral/extraoral defect treated with proton?radiation therapy. J Prosthet Dent. 2017 Apr; 117(4):563-565.
Score: 0.143
-
Salivary flow rates measured during radiation therapy in head and neck cancer patients: a pilot study assessing salivary sediment formation. J Prosthet Dent. 2008 Aug; 100(2):142-6.
Score: 0.081
-
Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008 Nov 01; 72(3):747-55.
Score: 0.079
-
Psychosocial and economic impact of cancer. Dent Clin North Am. 2008 Jan; 52(1):231-52, x.
Score: 0.077
-
Open-label, long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J Radiat Oncol Biol Phys. 2007 Dec 01; 69(5):1369-76.
Score: 0.076
-
Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1110-20.
Score: 0.074
-
Erratum to "Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study". Oral Oncol. 2007 Jan; 43(1):98-105.
Score: 0.072
-
Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 1: Fluorides. Oral Oncol. 2006 Oct; 42(9):934-45.
Score: 0.070
-
Clinical evaluation of the intraoral fluoride releasing system in radiation-induced xerostomic subjects. Part 2: Phase I study. Oral Oncol. 2006 Oct; 42(9):946-53.
Score: 0.069
-
Intensity-modulated radiotherapy: is xerostomia still prevalent? Curr Oncol Rep. 2005 Mar; 7(2):131-6.
Score: 0.064
-
Phase II Trial of Induction Chemotherapy for Advanced Sinonasal Squamous Cell Carcinoma. Clin Cancer Res. 2024 Nov 12.
Score: 0.062
-
Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management. Head Neck. 2004 Sep; 26(9):796-807.
Score: 0.062
-
Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep. 2022 04 22; 12(1):6662.
Score: 0.052
-
Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck. 2022 04; 44(4):952-963.
Score: 0.051
-
Factors associated with complex oral treatment device usage in patients with head and neck cancer. Clin Transl Radiat Oncol. 2021 Sep; 30:78-83.
Score: 0.050
-
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer. 2021 12 01; 127(23):4470-4480.
Score: 0.050
-
Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience. Int J Part Ther. 2021; 8(1):108-118.
Score: 0.049
-
Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. Radiat Oncol. 2019 Aug 19; 14(1):148.
Score: 0.043
-
Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer. 2020 Jan; 28(1):261-269.
Score: 0.042
-
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018 01; 126(1):75-80.
Score: 0.039
-
Design and fabrication of a 3D-printed oral stent for head and neck radiotherapy from routine diagnostic imaging. 3D Print Med. 2017; 3(1):12.
Score: 0.038
-
Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol. 2017 06; 123(3):401-405.
Score: 0.037
-
Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: a SEER-Medicare analysis. Head Neck. 2013 Nov; 35(11):1599-605.
Score: 0.027
-
Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):986-93.
Score: 0.025
-
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis. Int J Radiat Oncol Biol Phys. 2008 Dec 01; 72(5):1355-61.
Score: 0.020
-
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007 Oct; 29(10):923-31.
Score: 0.019
-
Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy. Int J Radiat Oncol Biol Phys. 2006 Apr 01; 64(5):1559-69.
Score: 0.017
-
A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiat Oncol Biol Phys. 2004 Mar 01; 58(3):674-81.
Score: 0.015
-
Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients. J Oral Maxillofac Surg. 2004 Feb; 62(2):139-44.
Score: 0.015